Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting Downstream Type 2 Cytokines or Upstream Epithelial Alarmins for Severe Asthma
Rory Chan, Kirsten Stewart, Rasads Misirovs, et al.
The Journal of Allergy and Clinical Immunology In Practice (2022) Vol. 10, Iss. 6, pp. 1497-1505
Open Access | Times Cited: 49

Showing 1-25 of 49 citing articles:

Type 2 chronic inflammatory diseases: targets, therapies and unmet needs
Pavel Kolkhir, Cezmi A. Akdiş, Mübeccel Akdiş, et al.
Nature Reviews Drug Discovery (2023) Vol. 22, Iss. 9, pp. 743-767
Closed Access | Times Cited: 67
Airway hyperresponsiveness in asthma: The role of the epithelium
Peter Bradding, Celeste Porsbjerg, Andréanne Côté, et al.
Journal of Allergy and Clinical Immunology (2024) Vol. 153, Iss. 5, pp. 1181-1193
Open Access | Times Cited: 21
Modulation of IL-4/IL-13 cytokine signaling in the context of allergic disease
Archana Shankar, Jaclyn W. McAlees, Ian Lewkowich
Journal of Allergy and Clinical Immunology (2022) Vol. 150, Iss. 2, pp. 266-276
Open Access | Times Cited: 38
Role of IL-33-ST2 pathway in regulating inflammation: current evidence and future perspectives
Yilu Zhou, Zhendong Xu, Zhiqiang Liu
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 23
Impaired Respiratory System Resistance and Reactance Are Associated With Bronchial Wall Thickening in Persistent Asthma
Rory Chan, Chary Duraikannu, Mohamed Jaushal Thouseef, et al.
The Journal of Allergy and Clinical Immunology In Practice (2023) Vol. 11, Iss. 5, pp. 1459-1462.e3
Open Access | Times Cited: 20
Allergen immunotherapy for allergic asthma: The future seems bright
Zuzana Diamant, Maurits van Maaren, Antonella Muraro, et al.
Respiratory Medicine (2023) Vol. 210, pp. 107125-107125
Open Access | Times Cited: 18
Thymic Stromal Lymphopoietin and Tezepelumab in Airway Diseases: From Physiological Role to Target Therapy
Diego Bagnasco, Laura De Ferrari, Benedetta Bondi, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 5972-5972
Open Access | Times Cited: 6
Impact of Biologic Therapy on the Small Airways Asthma Phenotype
Rory Chan, Brian J. Lipworth
Lung (2022) Vol. 200, Iss. 6, pp. 691-696
Open Access | Times Cited: 25
Clinical Associations of Mucus Plugging in Moderate to Severe Asthma
Rory Chan, Chary Duraikannu, Brian J. Lipworth
The Journal of Allergy and Clinical Immunology In Practice (2022) Vol. 11, Iss. 1, pp. 195-199.e2
Open Access | Times Cited: 23
Efficacy of biologic therapy on airway hyperresponsiveness in asthma
Rory Chan, Brian J. Lipworth
Annals of Allergy Asthma & Immunology (2023) Vol. 131, Iss. 1, pp. 37-41
Open Access | Times Cited: 16
Severe Fungal Asthma: A Role for Biologics and Inhaled Antifungals
Richard B. Moss
Journal of Fungi (2023) Vol. 9, Iss. 1, pp. 85-85
Open Access | Times Cited: 15
Ferroptosis triggers airway inflammation in asthma
Minming Li, Min Li, Yunjiao Hou, et al.
Therapeutic Advances in Respiratory Disease (2023) Vol. 17
Open Access | Times Cited: 13
Biologics and airway remodeling in asthma: early, late, and potential preventive effects
Gilda Varricchi, Remo Poto, Marek Lommatzsch, et al.
Allergy (2024) Vol. 80, Iss. 2, pp. 408-422
Open Access | Times Cited: 5
The last step to achieve barrier damage control
Ilaria Baglivo, Stefania Colantuono, Arianna Lumaca, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4
The epithelium takes the stage in asthma and inflammatory bowel diseases
Rocío López-Posadas, Dustin Bagley, Carlos Pardo-Pastor, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 4
Emerging biological treatments for asthma
Daniela Pastore, Chiara Lupia, Maria D’Amato, et al.
Expert Opinion on Emerging Drugs (2025)
Closed Access
Relationship Between Bronchodilator Reversibility and Spirometry Response to Dupilumab in Type 2 High Uncontrolled Severe Asthma
Robert Greig, Kirsten Stewart, Chris RuiWen Kuo, et al.
Clinical & Experimental Allergy (2025)
Open Access
Real-World Evidence of Administration of Biologic Agents in Patients with Severe Asthma: An Analysis of the Respiratory Department of University Hospital of Patras Asthma Registry
Ουρανία Παπαϊωάννου, Ioannis Christopoulos, Panagiota Tsiri, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 7, pp. 2174-2174
Open Access
A Real-world Study on Tezepelumab Effectiveness in Severe Asthma Focusing on Small Airway Dysfunction
Francesco Menzella, Marcello Cottini, Carlo Lombardi, et al.
Respiratory Medicine (2025), pp. 108054-108054
Closed Access
Head‐To‐Head Comparison of Biologic Efficacy in Asthma: What Have We Learned?
Brian J. Lipworth, Robert Greig, Rory Chan, et al.
Allergy (2025)
Open Access
Allergic bronchopulmonary aspergillosis successfully treated with tezepelumab
Osamu Matsuno
The Journal of Allergy and Clinical Immunology In Practice (2023) Vol. 11, Iss. 8, pp. 2589-2591
Closed Access | Times Cited: 7
An Updated Reappraisal of Dupilumab in Children and Adolescents with Severe Asthma
Gian Luigi Marseglia, Amelia Licari, Maria Angela Tosca, et al.
Children (2024) Vol. 11, Iss. 7, pp. 843-843
Open Access | Times Cited: 2
Novel Immunopharmacological Drugs for the Treatment of Allergic Diseases
Ekaterini Tiligada, Daria Gafarov, Maria Zaimi, et al.
The Annual Review of Pharmacology and Toxicology (2023) Vol. 64, Iss. 1, pp. 481-506
Closed Access | Times Cited: 6
Identification of pyroptosis-related subtypes and establishment of prognostic model and immune characteristics in asthma
Fan Yang, Tieshan Wang, Peizheng Yan, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 9
Anti-epithelial-derived cytokines for severe asthma: Systematic review and meta-analysis
Johnny Su, Tyler Pitre, Kairavi Desai, et al.
Journal of Allergy and Clinical Immunology (2023) Vol. 151, Iss. 6, pp. 1566-1576
Closed Access | Times Cited: 5
Page 1 - Next Page

Scroll to top